Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review

SIMPLE SUMMARY: Abiraterone acetate and enzalutamide are novel therapies used in advanced prostate cancer. However, their outcomes and toxicities may differ based on patient–specific factors. Understanding these differences may allow clinicians to make personalized treatment decisions based on indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Yash B., Shaver, Amy L., Beiriger, Jacob, Mehta, Sagar, Nikita, Nikita, Kelly, William Kevin, Freedland, Stephen J., Lu-Yao, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367458/
https://www.ncbi.nlm.nih.gov/pubmed/35954437
http://dx.doi.org/10.3390/cancers14153773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367458/
https://www.ncbi.nlm.nih.gov/pubmed/35954437
http://dx.doi.org/10.3390/cancers14153773

Ejemplares similares